SHARE
COPY LINK

EBOLA

Suspected Ebola case near Paris a false alarm

UPDATED: A building belonging to French health authorities was cordoned off on the outskirts of Paris on Thursday after a suspected case of Ebola was reported. Around sixty people were effectively quarantined but authorities later confirmed it was a false alarm.

Suspected Ebola case near Paris a false alarm
The suspected Ebola case was reported in th suburb of Cergy-Pontoise, to the north west of Paris. Image: Google Maps

LATEST: 'Probable' Ebola case probed at Paris hospital

A building in the suburb of Cergy-Pointoise, to the north west of Paris was cordoned off on Thursday after the alarm was ras raised that at least one person had fallen ill with 'Ebola-like symptoms".

It was reported the sick person had recently visited Guinea, one of the countries in West Africa hit badly by an Ebola outbreak that has killed thousands.

The prefect of Val-d'Oise Jean-Luc Nevache said the building was cordoned off so checks could be carried out and the move was made "as a precaution".

Accordng to RTL radio, around 60 people, some of whom recently visited Guinea, were effectively quarantined and a security cordon was set up around the building. Those inside were asked to remain where they were.

However later in the evening Nevache confirmed that the "suspicion was over" and the workers were allowed to leave.

Le Parisien newspaper reported that the alarm was raised when one of four people "of African origin" who had recently visited Gunea fell ill in the building and two others showed flu-like symptoms.

Those four were kept separate while medical tests were carried out to determine whether fears they had been infected by Ebola proved true, but authorities later confirmed the tests were negative.

France is on high alert to prevent the spread of Ebola. The government insists that it is ready to cope in the case of an outbreak but none have been reported up until now.

A French nurse who contacted Ebola in West Africa was recently cured of the disease after returning to France for treatment.

A Spanish nurse, who contacted the disease after treating an Ebola patient remains in a critical condition in Madrid.

France announced on Thursday that it will step up health checks at airports in the West African countries hit by the virus to try and prevent it spreading.

Fears are high that it is only a matter of time before someone is infected with the disease in France, with scientists from the UK suggesting that there was a 75 percent chance Ebola will arrive in France before the end of the month.

More to follow

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

EBOLA

Spanish researchers develop five-strain vaccine against lethal Ebola virus

Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday (July 11).

Spanish researchers develop five-strain vaccine against lethal Ebola virus
Ebola protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time. Photo: AFP

A prototype vaccine developed by pharmaceutical group Merck is already in use, but acts only against the most virulent, “Zaire” strain.

Despite not having market approval, Merck's rVSV-ZEBOV was administered to people in the Democratic Republic of Congo in May, with UN approval, in a bid to contain an outbreak of the same virus that killed more than 11,300 in three West African countries from 2013 to 2015, sparking international panic.

For several months, a team from the October 12 Hospital has been working with researchers at two other hospitals in the capital to examine and learn from blood samples taken from three people cured of Ebola in Spain.

Lead researcher Rafael Delgado told reporters the difficulty lay in the fact that the virus protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time.

That makes it tough for the body's immune system to fight the virus.

The three Spanish patients had produced “very effective” viral antibodies, though in a “small quantity” and only against the Zaire strain they were contaminated with.

Delgado, head of microbiology at the hospital, said researchers are aiming to reproduce these antibodies on a larger scale, and in a way that would make them efficient against all five virus strains.

US medical giant Johnson & Johnson is separately developing an experimental vaccine against two Ebola strains.

Delgado said researchers hope to get results from mouse experiments within a year.

The Ebola epidemic caused alarm in Spain in 2014 when a nursing assistant, Teresa Romero, became the first person infected outside Africa.

She caught the disease while tending to a Spanish missionary repatriated from Sierra Leone, who died in Spain in September that year.